Follow the people · Insider
John David Finley
John David Finley files insider transactions with the SEC as a ceo, cfo of Palisade Bio (PALI). We hold 2 disclosed purchases and sales filed since 29 April 2021, 1 of them in the last 90 days.
- Files forPALI
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure21 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 April 2021 — 19 August 2026CEO, CFO · Palisade Bio (PALI)112 Form 4 lines · source: SEC Form 4
Everything they disclosed
112 entries, newest first — one per disclosure report, one per Form 4 line- gave away 88,400 shares of Palisade BioSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- gave away 88,400 shares of Palisade BioSEC Form 421 August 2026Common Stock · traded 19 August 2026 · filed 21 August 2026
- exercised options over 335,167 shares of Palisade BioSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- ▼ sold on the open market 146,798 shares of Palisade BioSEC Form 48 July 2026Common Stock · traded 7 July 2026 · filed 8 July 2026
- exercised options over 133 shares of Palisade BioSEC Form 48 July 2026Common Stock · traded 7 July 2026 · filed 8 July 2026
- exercised options over 335,167 shares of Palisade Bio (a derivative holding)SEC Form 48 July 2026Restricted Stock Units · traded 6 July 2026 · filed 8 July 2026
- exercised options over 133 shares of Palisade Bio (a derivative holding)SEC Form 48 July 2026Series 2 Common Stock Purchase Warrant · traded 7 July 2026 · filed 8 July 2026
- exercised options over 13,333 shares of Palisade BioSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- ▼ sold on the open market 3,896 shares of Palisade BioSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- exercised options over 13,333 shares of Palisade Bio (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- exercised options over 13,333 shares of Palisade Bio (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- exercised options over 13,333 shares of Palisade BioSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- ▼ sold on the open market 3,896 shares of Palisade BioSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- was granted 2,011,000 shares of Palisade Bio (a derivative holding)SEC Form 411 February 2026Restricted Stock Units · traded 9 February 2026 · filed 11 February 2026
- was granted 2,011,000 shares of Palisade Bio (a derivative holding)SEC Form 411 February 2026Restricted Stock Units · traded 9 February 2026 · filed 11 February 2026
- was granted 9,179,400 shares of Palisade Bio (a derivative holding)SEC Form 48 October 2025Restricted Stock Units · traded 6 October 2025 · filed 8 October 2025
- was granted 323,400 shares of Palisade Bio (a derivative holding)SEC Form 45 September 2025Phantom Units · traded 4 September 2025 · filed 5 September 2025
- was granted 47,000 shares of Palisade Bio (a derivative holding)SEC Form 413 February 2025Stock Option (Right to Buy) · traded 11 February 2025 · filed 13 February 2025
- was granted 40,000 shares of Palisade Bio (a derivative holding)SEC Form 413 February 2025Restricted Stock Units · traded 11 February 2025 · filed 13 February 2025
- exercised options over 1,622 shares of Palisade Bio (a derivative holding)SEC Form 430 May 2024Restricted Stock Units · traded 28 May 2024 · filed 30 May 2024
- exercised options over 3,335 shares of Palisade Bio (a derivative holding)SEC Form 430 May 2024Restricted Stock Units · traded 28 May 2024 · filed 30 May 2024
- exercised options over 2,111 shares of Palisade Bio (a derivative holding)SEC Form 430 May 2024Restricted Stock Units · traded 28 May 2024 · filed 30 May 2024
- exercised options over 1,622 shares of Palisade BioSEC Form 430 May 2024Common Stock, par value $0.01 · traded 28 May 2024 · filed 30 May 2024
- had shares withheld for tax on 467 shares of Palisade BioSEC Form 430 May 2024Common Stock, par value $0.01 · traded 28 May 2024 · filed 30 May 2024
- exercised options over 3,335 shares of Palisade BioSEC Form 430 May 2024Common Stock, par value $0.01 · traded 28 May 2024 · filed 30 May 2024
- had shares withheld for tax on 959 shares of Palisade BioSEC Form 430 May 2024Common Stock, par value $0.01 · traded 28 May 2024 · filed 30 May 2024
- exercised options over 2,111 shares of Palisade BioSEC Form 430 May 2024Common Stock, par value $0.01 · traded 28 May 2024 · filed 30 May 2024
- had shares withheld for tax on 607 shares of Palisade BioSEC Form 430 May 2024Common Stock, par value $0.01 · traded 28 May 2024 · filed 30 May 2024
- ▲ bought on the open market 1,000 shares of Palisade BioSEC Form 428 May 2024Common Stock, par value $0.01 · traded 24 May 2024 · filed 28 May 2024
- was granted 666 shares of Palisade BioSEC Form 422 May 2024Common Stock, par value $0.01 · traded 20 May 2024 · filed 22 May 2024
- exercised options over 232 shares of Palisade Bio (a derivative holding)SEC Form 48 May 2024Restricted Stock Units · traded 6 May 2024 · filed 8 May 2024
- exercised options over 211 shares of Palisade Bio (a derivative holding)SEC Form 48 May 2024Restricted Stock Units · traded 6 May 2024 · filed 8 May 2024
- exercised options over 232 shares of Palisade BioSEC Form 48 May 2024Common Stock, par value $0.01 · traded 6 May 2024 · filed 8 May 2024
- had shares withheld for tax on 67 shares of Palisade BioSEC Form 48 May 2024Common Stock, par value $0.01 · traded 6 May 2024 · filed 8 May 2024
- exercised options over 211 shares of Palisade BioSEC Form 48 May 2024Common Stock, par value $0.01 · traded 6 May 2024 · filed 8 May 2024
- had shares withheld for tax on 61 shares of Palisade BioSEC Form 48 May 2024Common Stock, par value $0.01 · traded 6 May 2024 · filed 8 May 2024
- exercised options over 5,558 shares of Palisade Bio (a derivative holding)SEC Form 412 March 2024Restricted Stock Units · traded 11 March 2024 · filed 12 March 2024
- exercised options over 5,558 shares of Palisade BioSEC Form 412 March 2024Common Stock, par value $0.01 · traded 11 March 2024 · filed 12 March 2024
- exercised options over 3,475 shares of Palisade Bio (a derivative holding)SEC Form 48 February 2024Restricted Stock Units · traded 6 February 2024 · filed 8 February 2024
- exercised options over 3,167 shares of Palisade Bio (a derivative holding)SEC Form 48 February 2024Restricted Stock Units · traded 6 February 2024 · filed 8 February 2024
- exercised options over 3,475 shares of Palisade BioSEC Form 48 February 2024Common Stock, par value $0.01 · traded 6 February 2024 · filed 8 February 2024
- exercised options over 3,167 shares of Palisade BioSEC Form 48 February 2024Common Stock, par value $0.01 · traded 6 February 2024 · filed 8 February 2024
- ▲ bought on the open market 10,000 shares of Palisade BioSEC Form 47 February 2024Common Stock, par value $0.01 · traded 6 February 2024 · filed 7 February 2024
- ▲ bought on the open market 10,000 shares of Palisade BioSEC Form 41 February 2024Common Stock, par value $0.01 · traded 31 January 2024 · filed 1 February 2024
- exercised options over 1,309 shares of Palisade Bio (a derivative holding)SEC Form 45 January 2024Restricted Stock Units · traded 3 January 2024 · filed 5 January 2024
- exercised options over 1,309 shares of Palisade BioSEC Form 45 January 2024Common Stock, par value $0.01 · traded 3 January 2024 · filed 5 January 2024
- exercised options over 5,559 shares of Palisade Bio (a derivative holding)SEC Form 419 December 2023Restricted Stock Units · traded 11 December 2023 · filed 19 December 2023
- exercised options over 5,559 shares of Palisade BioSEC Form 419 December 2023Common Stock, par value $0.01 · traded 11 December 2023 · filed 19 December 2023
- was granted 38,000 shares of Palisade Bio (a derivative holding)SEC Form 424 November 2023Restricted Stock Units · traded 21 November 2023 · filed 24 November 2023
- was granted 45,000 shares of Palisade Bio (a derivative holding)SEC Form 424 November 2023Common Stock Options · traded 21 November 2023 · filed 24 November 2023
- was granted 10,000 shares of Palisade BioSEC Form 424 November 2023Common Stock, par value $0.01 · traded 20 November 2023 · filed 24 November 2023
- exercised options over 3,475 shares of Palisade Bio (a derivative holding)SEC Form 48 November 2023Restricted Stock Units · traded 6 November 2023 · filed 8 November 2023
- exercised options over 3,475 shares of Palisade BioSEC Form 48 November 2023Common Stock, par value $0.01 · traded 6 November 2023 · filed 8 November 2023
- exercised options over 1,309 shares of Palisade Bio (a derivative holding)SEC Form 45 October 2023Restricted Stock Units · traded 3 October 2023 · filed 5 October 2023
- exercised options over 1,309 shares of Palisade BioSEC Form 45 October 2023Common Stock, par value $0.01 · traded 3 October 2023 · filed 5 October 2023
- had shares withheld for tax on 397 shares of Palisade BioSEC Form 45 October 2023Common Stock, par value $0.01 · traded 4 October 2023 · filed 5 October 2023
- ▲ bought on the open market 15,000 shares of Palisade BioSEC Form 429 September 2023Common Stock, par value $0.01 · traded 27 September 2023 · filed 29 September 2023
- ▲ bought on the open market 15,000 shares of Palisade BioSEC Form 414 September 2023Common Stock, par value $0.01 · traded 13 September 2023 · filed 14 September 2023
- exercised options over 5,558 shares of Palisade Bio (a derivative holding)SEC Form 413 September 2023Restricted Stock Units · traded 11 September 2023 · filed 13 September 2023
- exercised options over 5,558 shares of Palisade BioSEC Form 413 September 2023Common Stock, par value $0.01 · traded 11 September 2023 · filed 13 September 2023
- had shares withheld for tax on 1,792 shares of Palisade BioSEC Form 413 September 2023Common Stock, par value $0.01 · traded 12 September 2023 · filed 13 September 2023
- exercised options over 3,475 shares of Palisade Bio (a derivative holding)SEC Form 414 August 2023Restricted Stock Units · traded 6 August 2023 · filed 14 August 2023
- exercised options over 3,475 shares of Palisade BioSEC Form 414 August 2023Common Stock, par value $0.01 · traded 6 August 2023 · filed 14 August 2023
- had shares withheld for tax on 1,040 shares of Palisade BioSEC Form 414 August 2023Common Stock, par value $0.01 · traded 11 August 2023 · filed 14 August 2023
- exercised options over 1,309 shares of Palisade Bio (a derivative holding)SEC Form 46 July 2023Restricted Stock Units · traded 3 July 2023 · filed 6 July 2023
- exercised options over 1,309 shares of Palisade BioSEC Form 46 July 2023Common Stock, par value $0.01 · traded 3 July 2023 · filed 6 July 2023
- had shares withheld for tax on 389 shares of Palisade BioSEC Form 46 July 2023Common Stock, par value $0.01 · traded 6 July 2023 · filed 6 July 2023
- exercised options over 3,475 shares of Palisade Bio (a derivative holding)SEC Form 414 June 2023Restricted Stock Units · traded 12 June 2023 · filed 14 June 2023
- exercised options over 3,475 shares of Palisade BioSEC Form 414 June 2023Common Stock, par value $0.01 · traded 12 June 2023 · filed 14 June 2023
- had shares withheld for tax on 1,050 shares of Palisade BioSEC Form 414 June 2023Common Stock, par value $0.01 · traded 13 June 2023 · filed 14 June 2023
- was granted 66,700 shares of Palisade Bio (a derivative holding)SEC Form 413 June 2023Restricted Stock Units · traded 11 June 2023 · filed 13 June 2023
- was granted 148,500 shares of Palisade Bio (a derivative holding)SEC Form 413 June 2023Common Stock Options · traded 11 June 2023 · filed 13 June 2023
- exercised options over 1,309 shares of Palisade Bio (a derivative holding)SEC Form 45 April 2023Restricted Stock Units · traded 3 April 2023 · filed 5 April 2023
- exercised options over 1,309 shares of Palisade BioSEC Form 45 April 2023Common Stock, par value $0.01 · traded 3 April 2023 · filed 5 April 2023
- had shares withheld for tax on 435 shares of Palisade BioSEC Form 45 April 2023Common Stock, par value $0.01 · traded 3 April 2023 · filed 5 April 2023
- was granted 41,700 shares of Palisade Bio (a derivative holding)SEC Form 48 February 2023Restricted Stock Units · traded 6 February 2023 · filed 8 February 2023
- was granted 32,500 shares of Palisade Bio (a derivative holding)SEC Form 48 February 2023Restricted Performance Stock Units · traded 6 February 2023 · filed 8 February 2023
- was granted 57,200 shares of Palisade Bio (a derivative holding)SEC Form 48 February 2023Common Stock Purchase Option · traded 6 February 2023 · filed 8 February 2023
- was granted 5,236 shares of Palisade Bio (a derivative holding)SEC Form 46 January 2023Restricted Stock Units · traded 3 January 2023 · filed 6 January 2023
- ▲ bought on the open market 19,481 shares of Palisade BioSEC Form 42 September 2022Common Stock, par value $0.01 · traded 1 September 2022 · filed 2 September 2022
- ▲ bought on the open market 7,350 shares of Palisade BioSEC Form 425 August 2022Common Stock, par value $0.01 · traded 23 August 2022 · filed 25 August 2022
- ▲ bought on the open market 100,000 shares of Palisade Bio (a derivative holding)SEC Form 418 August 2022Series 1 Common Stock Purchase Warrant · traded 16 August 2022 · filed 18 August 2022
- ▲ bought on the open market 100,000 shares of Palisade Bio (a derivative holding)SEC Form 418 August 2022Series 2 Common Stock Purchase Warrant · traded 16 August 2022 · filed 18 August 2022
- ▲ bought on the open market 100,000 shares of Palisade BioSEC Form 418 August 2022Common Stock, par value $0.01 · traded 16 August 2022 · filed 18 August 2022
- acquired or disposed of, other 12,545 shares of Palisade BioSEC Form 42 May 2022Common Stock · traded 29 April 2022 · filed 2 May 2022
- ▲ bought on the open market 7,500 shares of Palisade BioSEC Form 425 March 2022Common Stock · traded 24 March 2022 · filed 25 March 2022
- was granted 64,800 shares of Palisade Bio (a derivative holding)SEC Form 422 February 2022Stock Option (right to buy) · traded 17 February 2022 · filed 22 February 2022
- was granted 178,091 shares of Palisade Bio (a derivative holding)SEC Form 410 February 2022Stock Option (right to buy) · traded 18 November 2021 · filed 10 February 2022
- ▲ bought on the open market 2,000 shares of Palisade BioSEC Form 422 September 2021Common Stock · traded 21 September 2021 · filed 22 September 2021
- ▲ bought on the open market 1,600 shares of Palisade BioSEC Form 430 August 2021Common Stock · traded 27 August 2021 · filed 30 August 2021
- ▲ bought on the open market 8,400 shares of Palisade BioSEC Form 430 August 2021Common Stock · traded 27 August 2021 · filed 30 August 2021
- was granted 2,396 shares of Palisade BioSEC Form 429 April 2021Common Stock · traded 27 April 2021 · filed 29 April 2021
- was granted 26,322 shares of Palisade BioSEC Form 429 April 2021Common Stock · traded 27 April 2021 · filed 29 April 2021
- was granted 10,418 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 9,516 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 52,068 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 14,708 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 5,662 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 19,033 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 9,702 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 7,952 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 2,595 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Stock Option (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 95 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 51 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 49 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 339 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 503 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 40 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 516 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 27 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 325 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
- was granted 293 shares of Palisade Bio (a derivative holding)SEC Form 429 April 2021Warrant (Right to Buy) · traded 27 April 2021 · filed 29 April 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.